Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 34% ± 16% | |
oligodendrocyte precursor cell | 11 studies | 32% ± 11% | |
glutamatergic neuron | 10 studies | 49% ± 26% | |
oligodendrocyte | 10 studies | 30% ± 12% | |
GABAergic neuron | 8 studies | 44% ± 22% | |
interneuron | 6 studies | 45% ± 17% | |
neuron | 5 studies | 39% ± 11% | |
endothelial cell | 5 studies | 35% ± 16% | |
retinal rod cell | 5 studies | 45% ± 18% | |
epithelial cell | 4 studies | 26% ± 11% | |
microglial cell | 4 studies | 29% ± 14% | |
retinal cone cell | 4 studies | 26% ± 9% | |
GABAergic interneuron | 3 studies | 30% ± 6% | |
granule cell | 3 studies | 30% ± 12% | |
GABAergic amacrine cell | 3 studies | 30% ± 12% | |
amacrine cell | 3 studies | 29% ± 9% | |
glycinergic amacrine cell | 3 studies | 24% ± 7% | |
retina horizontal cell | 3 studies | 30% ± 10% | |
ependymal cell | 3 studies | 40% ± 12% | |
ciliated cell | 3 studies | 35% ± 9% | |
fibroblast | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 239.31 | 1431 / 1445 | 99% | 4.54 | 182 / 183 |
brain | 99% | 368.71 | 2616 / 2642 | 99% | 4.80 | 698 / 705 |
prostate | 100% | 373.43 | 245 / 245 | 94% | 3.39 | 473 / 502 |
breast | 98% | 432.02 | 452 / 459 | 94% | 3.80 | 1046 / 1118 |
thymus | 100% | 487.39 | 653 / 653 | 92% | 2.80 | 554 / 605 |
ovary | 100% | 529.81 | 180 / 180 | 91% | 2.63 | 390 / 430 |
pancreas | 99% | 234.14 | 326 / 328 | 90% | 2.31 | 160 / 178 |
lung | 99% | 281.82 | 572 / 578 | 89% | 2.78 | 1027 / 1155 |
bladder | 100% | 292.00 | 21 / 21 | 86% | 2.42 | 431 / 504 |
uterus | 100% | 434.40 | 170 / 170 | 82% | 2.50 | 375 / 459 |
stomach | 96% | 203.23 | 346 / 359 | 84% | 2.22 | 240 / 286 |
adrenal gland | 100% | 521.42 | 257 / 258 | 78% | 2.04 | 180 / 230 |
intestine | 97% | 276.83 | 939 / 966 | 79% | 1.85 | 414 / 527 |
kidney | 99% | 237.80 | 88 / 89 | 71% | 1.68 | 642 / 901 |
skin | 100% | 658.82 | 1807 / 1809 | 60% | 1.38 | 282 / 472 |
spleen | 100% | 330.30 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 276.86 | 1190 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 224.37 | 1288 / 1335 | 0% | 0 | 0 / 0 |
heart | 85% | 150.51 | 732 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 2.14 | 37 / 45 |
liver | 41% | 45.04 | 93 / 226 | 11% | 0.21 | 46 / 406 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.43 | 13 / 29 |
eye | 0% | 0 | 0 / 0 | 31% | 0.51 | 25 / 80 |
peripheral blood | 30% | 172.29 | 279 / 929 | 0% | 0 | 0 / 0 |
muscle | 15% | 19.31 | 123 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_1905515 | Biological process | non-motile cilium assembly |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0061512 | Biological process | protein localization to cilium |
GO_0060021 | Biological process | roof of mouth development |
GO_0001822 | Biological process | kidney development |
GO_0060831 | Biological process | smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
GO_0007507 | Biological process | heart development |
GO_0007368 | Biological process | determination of left/right symmetry |
GO_0003406 | Biological process | retinal pigment epithelium development |
GO_0005929 | Cellular component | cilium |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | TBC1D32 |
Protein name | TBC1 domain family member 32 Protein broad-minded (TBC1 domain family member 32) |
Synonyms | C6orf170 C6orf171 BROMI |
Description | FUNCTION: Required for high-level Shh responses in the developing neural tube. Together with CDK20, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to Shh signaling (By similarity). . |
Accessions | ENST00000275159.11 [Q96NH3-4] A2A304 ENST00000422369.1 H0YBP0 ENST00000398212.7 [Q96NH3-1] ENST00000509492.2 Q96NH3 ENST00000464622.5 [Q96NH3-5] |